Global Spinal Implants And Surgical Devices Databank Market Report
The Spinal Implants And Surgical Devices market was valued at $12,731.6 Million in 2022, and is projected to reach $18,497.3 Million by 2031 growing at a CAGR of 4.28% from 2023 to 2031. Spinal Bone Growth Stimulators segment is expected to be the highest contributor to this market, with $6,529.9 Million in 2022, and is anticipated to reach $10,157.7 Million by 2031, registering a CAGR of 5.07%. Spinal Biologics segment is anticipated to reach $1,953.2 Million by 2031 with the highest CAGR of 7.79%. Spinal Bone Growth Stimulators and Spinal Fusion Devices segments collectively expected to account for about 66.3% share of the Spinal Implants And Surgical Devices market in 2022, with the former constituting around 51.3% share. Spinal Biologics and Spinal Bone Growth Stimulators segments are expected to witness significant growth rates at a CAGR of 7.79% and 5.07% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 59.1% in the overall Spinal Implants And Surgical Devices market in 2022, and is anticipated to reach 65.5% by 2031.
1. Global Spinal Implants And Surgical Devices Market, By Product
1.1. Overview
1.2. Spinal Fusion Devices
1.2.1 Spinal Fusion Devices Market, By Region
1.2.1.1 North America Spinal Fusion Devices Market, By Country
1.2.1.2 Europe Spinal Fusion Devices Market, By Country
1.2.1.3 Asia-Pacific Spinal Fusion Devices Market, By Country
1.2.1.4 Rest of World Spinal Fusion Devices Market, By Country
1.3. Spinal Biologics
1.3.1 Spinal Biologics Market, By Region
1.3.1.1 North America Spinal Biologics Market, By Country
1.3.1.2 Europe Spinal Biologics Market, By Country
1.3.1.3 Asia-Pacific Spinal Biologics Market, By Country
1.3.1.4 Rest of World Spinal Biologics Market, By Country